Nizubaglustat
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Nizubaglustat, covering 2026-03-19 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis [Phase 3]